RxDoctor Payments Data

Jon Tosino, MD

Family Medicine · Hudson, OHNPI 1912960808

Payments from drug & device makers

$22,194in general payments, 2019–2025

Across 1,537 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Pfizer$2K
  • Novo Nordisk$2K
  • GSK$2K
  • AstraZeneca$1K
  • Astellas Pharma US Inc$1K
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$21,74298%
  • Education$4522%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)303$4,472
Pfizer184$2,258
Novo Nordisk155$1,662
GSK134$1,620
AstraZeneca69$1,219
Astellas Pharma US Inc58$1,193
Lilly USA, LLC85$1,166
Amarin Pharma, Inc.56$844
Amgen48$745
Boehringer Ingelheim47$567
Merck40$545
Bayer25$467
Biohaven Pharmaceutical Holding Company Ltd.35$422
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC26$392
Takeda Pharmaceuticals U.S.A., Inc.22$299
Abbott16$289
Lundbeck LLC15$281
Exact Sciences14$280
Teva Pharmaceuticals USA, Inc.16$232
Biohaven Pharmaceuticals, Inc.18$208
Johnson & Johnson12$202
Jazz Pharmaceuticals Inc.10$192
Novartis11$188
Nestle Healthcare Nutrition Inc.9$165
Corcept Therapeutics8$159
Supernus Pharmaceuticals, Inc.9$143
Phathom Pharmaceuticals, Inc.7$143
Idorsia Pharmaceuticals US Inc7$129
Eisai Inc.8$117
Smith+Nephew1$116
Axsome Therapeutics, Inc.5$112
Genentech USA, Inc.7$112
Daiichi Sankyo Inc.6$106
Kowa Pharmaceuticals America, Inc.7$85
Ironwood Pharmaceuticals, Inc6$85
Esperion Therapeutics, Inc.4$73
Nevro Corp.3$66
Otsuka America Pharmaceutical, Inc.3$66
Sumitomo Pharma America, Inc.3$62
Shire North American Group Inc3$57
Xeris Pharmaceuticals, Inc.3$50
Mylan Specialty L.p.3$50
Clarus Therapeutics Inc.3$44
Vivus LLC3$42
Dexcom, Inc.2$37
IBSA Pharma Inc.2$36
Sanofi Pasteur Inc.2$33
Collegium Pharmaceutical, Inc.2$32
Alfasigma USA, Inc.2$30
Radius Health, Inc.2$29
Bausch Health US, LLC2$22
Inspire Medical Systems, Inc.1$22
Ultragenyx Pharmaceutical Inc.1$20
Upsher-smith Laboratories LLC1$19
Antares Pharma, Inc.1$18
Endo Pharmaceuticals Inc.1$17
Dermira, Inc.1$16
Currax Pharmaceuticals LLC1$15
Halozyme Inc1$15
Eyevance Pharmaceuticals LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,194 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$24,182
Medicare patients
146
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$73,263
JardianceEmpagliflozin36$54,163
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$22,574
MounjaroTirzepatide16$21,454
OzempicSemaglutide13$20,548
MyrbetriqMirabegron23$18,664
JanuviaSitagliptin Phosphate15$18,076
TradjentaLinagliptin14$12,442
Breo ElliptaFluticasone/Vilanterol13$5,838
Serevent DiskusSalmeterol Xinafoate12$4,863
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen108$2,861
Omeprazole143$2,683
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen120$2,678
Levothyroxine Sodium212$2,349
Gabapentin99$2,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$2,258$73,26364 claims
Boehringer IngelheimJardiance, Tradjenta$567$66,60550 claims
GSKTrelegy Ellipta, Breo Ellipta$1,620$28,41237 claims
Lilly USA, LLCMounjaro$1,166$21,45416 claims
Novo NordiskOzempic$1,662$20,54813 claims
Astellas Pharma US IncMyrbetriq$1,193$18,66423 claims
MerckJanuvia$545$18,07615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Hudson

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →